Chromocell Therapeutics Corporation (CHRO) — Defensive Interval Ratio
Chromocell Therapeutics Corporation (CHRO) has a Defensive Interval Ratio of 2 days as of June 2025. Defensive assets of $40.40K (cash $-, short-term investments $-, receivables $40.40K) cover 2 days of daily cash needs of $20.05K/day. For the complete balance sheet picture, see Chromocell Therapeutics Corporation balance sheet assets.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Chromocell Therapeutics Corporation Defensive Interval Ratio (2024–2024)
This chart shows how Chromocell Therapeutics Corporation's Defensive Interval Ratio has evolved across 1 annual periods from 2024 to 2024. As of June 2025, the ratio stands at 2 days, meaning defensive assets of $40.40K can fund 2 days of operations without new revenue. Read total liabilities of Chromocell Therapeutics Corporation for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Chromocell Therapeutics Corporation (2024–2024)
The table below presents the year-by-year Defensive Interval Ratio for Chromocell Therapeutics Corporation from 2024 to 2024, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 4 days | $40.40K | $11.19K/day | $- | $- | — |